The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Ranked by engagement

Top topics — this year page 11

Ranked by replies, likes and views over this year, with a bonus for topics that reached a marked solution. Engagement is a proxy for usefulness and a poor one; the documentation commons is the better index of what is settled.

1,076 topics · page 11 of 14

TopicParticipantsRepliesViewsActivity
Packaging that arrived damaged: documenting it properly — a second dataset
Posting this under the heading it deserves: Packaging that arrived damaged: documenting it properly — a second dataset Everything below is what sits behind that. A logistics question, since the answers here…
PIAKMAKBAN+68 73 20k 4mo
Revisiting: Liver enzymes drifting down and what that usually means
On the subject in the title: Revisiting: Liver enzymes drifting down and what that usually means Working notes rather than a conclusion. General question, not a request for advice about my own care — I know…
SSJFSTHEBE+55 61 39k 3h
Designing a personal experiment that could change your mind — one year on
Designing a personal experiment that could change your mind — one year on — setting out what I have, and where I think it stops being reliable. Session topic: STEP 4 ( JAMA , 2021). Please read it before…
TKNMPMBSMC+74 80 17k 2d
What to bring: records that a clinician can actually use — a second dataset
What to bring: records that a clinician can actually use — a second dataset I have a specific reason for asking rather than idle curiosity, and the context is below. Asking about a population rather than…
SRSRVFZYNV+80 86 5.6k 3h
Pinch or no pinch, and how needle length changes the answer — the long version
On the subject in the title: Pinch or no pinch, and how needle length changes the answer — the long version Working notes rather than a conclusion. I have read the maintained page on this and I still have a…
CBADAWTSAC+75 79 1.5k 1mo
Micro-titration: a disputed topic, argued properly — one year on
Posting this under the heading it deserves: Micro-titration: a disputed topic, argued properly — one year on Everything below is what sits behind that. A question about technique rather than about dose. I…
NSKRSICPAC+63 68 35k 1d
Prescription requirements and telehealth models — a second dataset
On the subject in the title: Prescription requirements and telehealth models — a second dataset Working notes rather than a conclusion. A logistics question, since the answers here are usually better than…
MOLAPFPHB+87 94 1.1k 21d
Pinch or no pinch, and how needle length changes the answer — what changed since
Posting this under the heading it deserves: Pinch or no pinch, and how needle length changes the answer — what changed since Everything below is what sits behind that. I have read the maintained page on this…
GRSSSVNEHA+58 62 16k 1d
Why catalogue breadth is not evidence of anything — what changed since
Asking directly, because I could not find a straight answer: Why catalogue breadth is not evidence of anything — what changed since Session topic: SURMOUNT-1 ( N Engl J Med , 2022). Please read it before…
NEHFDBBKLG+62 66 26k 10mo
Bug report: the reconstitution calculator and a rounding edge case
Bug report: the reconstitution calculator and a rounding edge case — setting out what I have, and where I think it stops being reliable. Working through the identity arithmetic and I would like it checked.…
PNCHROAHA+68 72 28k 4mo
Does a peptide degrade silently, with no visual change?
Does a peptide degrade silently, with no visual change? I have a specific reason for asking rather than idle curiosity, and the context is below. I have read the maintained page on this and I still have a…
EFMGVSNKN+73 79 1.3k 1d
Why the absence of controlled human data on BPC-157 matters more than people admit
Why the absence of controlled human data on BPC-157 matters more than people admit — that is the question, and I have not found it answered plainly anywhere I have looked. Comparing STEP 8 ( JAMA , 2022) with…
CMVMPFNBHF+60 66 16k 1d
Follow-up: Comparing two chromatograms from different laboratories, properly
Comparing two chromatograms from different laboratories, properly — setting out what I have, and where I think it stops being reliable. I would like to understand what this number means before I repeat it…
MMSSNCEFGA+62 67 12k 9h
A single out-of-range value on an otherwise normal panel
Posting this under the heading it deserves: A single out-of-range value on an otherwise normal panel Everything below is what sits behind that. General question, not a request for advice about my own care — I…
GDBVMSBNL+70 75 20k 6d
Revisiting: Drawing up with one needle and injecting with another
Revisiting: Drawing up with one needle and injecting with another Writing it up because I had to work it out twice and would rather nobody else did. Practical question with the units stated, because I have…
FRCTPFBSO+76 83 1.1k 4mo
Search filters: what is missing
Search filters: what is missing — setting out what I have, and where I think it stops being reliable. Nominating something for promotion into the documentation commons. The topic in question keeps being…
LEBAELHFSC+74 84 15k 3d
Fatigue in the first month: how much is the drug and how much is intake — what changed since
Fatigue in the first month: how much is the drug and how much is intake — what changed since Writing it up because I had to work it out twice and would rather nobody else did. I have read the maintained page…
GIASNPDBSD+77 82 1.2k 11mo
Semaglutide versus liraglutide head to head: reading STEP 8 carefully
On the subject in the title: Semaglutide versus liraglutide head to head: reading STEP 8 carefully Working notes rather than a conclusion. I have seen PIONEER 6 ( N Engl J Med , 2019) cited in support of a…
GNKDOJFDS+72 81 1.5k 9mo
Follow-up: Bug report: the reconstitution calculator and a rounding edge case
On the subject in the title: Bug report: the reconstitution calculator and a rounding edge case Working notes rather than a conclusion. Working through the identity arithmetic and I would like it checked.…
MMLCFAWRM+58 63 24k 5mo
Subgroup analyses: pre-specified versus discovered — a second dataset
On the subject in the title: Subgroup analyses: pre-specified versus discovered — a second dataset Working notes rather than a conclusion. Comparing SURMOUNT-1 ( N Engl J Med , 2022) with SURPASS-4 ( Lancet ,…
IDAMCILDC+71 79 906 3mo
Sleep quality changes during weight loss — what changed since
Sleep quality changes during weight loss — what changed since Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population rather than about a person. The…
KKOZIMSWM+68 74 10k 8mo
Nausea profile of amylin analogues compared with GLP-1 agonists
Nausea profile of amylin analogues compared with GLP-1 agonists Writing it up because I had to work it out twice and would rather nobody else did. Session topic: SURPASS-4 ( Lancet , 2021). Please read it…
CRIGELZAG+70 76 3k 4mo
Prior authorisation: what the criteria usually require — a second dataset
Posting this under the heading it deserves: Prior authorisation: what the criteria usually require — a second dataset Everything below is what sits behind that. A coverage question with the paperwork detail…
IIOCDTVGH+67 74 19k 21h
Completing a dose with a second syringe, and the dead-volume arithmetic
Posting this under the heading it deserves: Completing a dose with a second syringe, and the dead-volume arithmetic Everything below is what sits behind that. I have read the maintained page on this and I…
FPRMNSLMR+65 76 7.4k 1d
Cost per delivered dose, which is the number that matters
Cost per delivered dose, which is the number that matters — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that is what…
MYFTATRFAD+54 59 30k 4mo
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version — setting out what I have, and where I think it stops being reliable. Asking about a population rather than about a…
BVDTMBUCRV+64 69 15k 7mo
What pooling buys you and what it destroys
The question in the title: What pooling buys you and what it destroys I will give what I have already checked below so nobody repeats it. Comparing SURMOUNT-2 ( Lancet , 2023) with LEADER ( N Engl J Med ,…
MDEHDHPMNA+74 83 6.6k 8mo
Reporting a disappointing outcome, and why it belongs here
Reporting a disappointing outcome, and why it belongs here Writing it up because I had to work it out twice and would rather nobody else did. Longitudinal report with the method stated, because a number…
SSMOPPSDEV+21 29 62k 10mo
A widely repeated interaction claim that turns out to be unsupported
On the subject in the title: A widely repeated interaction claim that turns out to be unsupported Working notes rather than a conclusion. Practical question with the units stated, because I have seen how…
NKRGBNMSDT+47 51 37k 3mo
Storing lyophilised material long term: what governs the shelf life
On the subject in the title: Storing lyophilised material long term: what governs the shelf life Working notes rather than a conclusion. Practical question with the units stated, because I have seen how…
ZSFDLESGCL+83 90 1k 5mo